Drug recall · April 29, 2026
Furosemide Tablets recall
Why: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
- Lots / codes
Lots# H03125, H03225, H03325, Exp Date: 2027/08
- Quantity
- 9384 bottles
- Company
- Leading Pharma, LLC, Fairfield, NJ
- Distribution
- US Nationwide.
- Initiated
- March 20, 2026 · Voluntary: Firm initiated
- Classified
- April 21, 2026
- Reported
- April 29, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Furosemide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.